GreenLight Biosciences Holdings, PBC

GreenLight Biosciences Holdings, PBC is an RNA medicines and agricultural biotech company that agreed to merge with Environmental Impact Acquisition Corp, the Nasdaq-listed blank-check vehicle trading under the ticker ENVI, which completed its IPO in 2020 targeting the life sciences and environmental sectors. The 10-Q filed on May 24, 2021 covers a quarterly reporting period during which the de-SPAC business combination remained pending. GreenLight's platform spans RNA-based therapeutics for human health and crop-protection applications, placing the transaction squarely in the biotechnology sector. Sign up at SpacDesk for complete filing histories, deal timelines, and SPAC analytics on this transaction and hundreds more.